Immunome
IMNM
#4802
Rank
C$2.90 B
Marketcap
C$24.58
Share price
-2.44%
Change (1 day)
-3.51%
Change (1 year)

Earnings for Immunome (IMNM)

Earnings in 2026 (TTM): -C$0.38 Billion

According to Immunome's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.33 Billion a decrease over its 2024 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunome from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.38 Billion17.58%
2025 -C$0.33 Billion46.04%
2024 -C$0.22 Billion434.17%
2023 -C$41.11 Million-22.15%
2022 -C$52.8 Million46.39%
2021 -C$36.07 Million41.63%
2020 -C$25.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-42.27%๐Ÿ‡บ๐Ÿ‡ธ USA